Susquehanna International Group
FHTX icon

Susquehanna International Group’s Foghorn Therapeutics FHTX Stock Holding History

Susquehanna International Group’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.6K Buy
+11,637
New +$63.9K ﹤0.01% 12608
2025
Q3 		– Sell
-39,649
Closed -$186K – 12822
2025
Q2 		$186K Buy
39,649
+7,799
+24% +$32.6K ﹤0.01% 11282
2025
Q1 		$116K Buy
31,850
+16,052
+102% +$73.2K ﹤0.01% 11439
2024
Q4 		$74.6K Sell
15,798
-23,793
-60% -$173K ﹤0.01% 11506
2024
Q3 		$369K Buy
+39,591
New +$287K ﹤0.01% 9159
2024
Q2 		– Sell
-16,080
Closed -$108K – 12368
2024
Q1 		$108K Buy
16,080
+4,749
+42% +$26.4K ﹤0.01% 11172
2023
Q4 		$73.1K Sell
11,331
-20,007
-64% -$86.3K ﹤0.01% 11525
2023
Q3 		$157K Sell
31,338
-23,684
-43% -$183K ﹤0.01% 10504
2023
Q2 		$387K Buy
55,022
+42,365
+335% +$296K ﹤0.01% 8906
2023
Q1 		$78.5K Buy
+12,657
New +$82.8K ﹤0.01% 11446
2021
Q1 		– Sell
-27,939
Closed -$566K – 12416
2020
Q4 		$566K Buy
+27,939
New +$535K ﹤0.01% 8008

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Susquehanna International Group's FHTX Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Foghorn Therapeutics (FHTX) in Q1 2026: 11,637 shares worth $55.6K. The stake represents ﹤0.01% of the portfolio and ranks #12608 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in FHTX as recently as Q2 2025.

Susquehanna International Group first reported a position in FHTX in Q4 2020 and has held it in 11 quarters since. The position peaked at $566K in Q4 2020. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Susquehanna International Group held 11,637 shares of Foghorn Therapeutics worth $55.6K as of Q1 2026.
  • Foghorn Therapeutics was a new Susquehanna International Group position in Q1 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12608 holding.
  • Susquehanna International Group first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 11 quarters since.
  • Susquehanna International Group's Foghorn Therapeutics position peaked at $566K in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.